BI-0474   Click here for help

GtoPdb Ligand ID: 12279

Synonyms: BI 0474 | BI0474 | compound 23 [PMID: 36300829]
PDB Ligand
Compound class: Synthetic organic
Comment: BI-0474 is an inhibitor of the oncogenic protein KRASG12C [1]. It was designed to target KRASG12C-driven tumours but it is not orally bioactive. Boehringer have an alternative orally bioavailable analogue (BI 1823911) from the same series as BI-0474, in clinical development (NCT04973163), but its structure has not been disclosed (Nov. 2022).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 159.89
Molecular weight 587.28
XLogP 3.06
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C=CC(=O)N1CCN(CC1)c1cc(nc(c1)N1CCN(C[C@@H]1C)C)c1noc(n1)[C@@]1(C)CCCc2c1c(C#N)c(s2)N
Isomeric SMILES C[C@H]1CN(C)CCN1c1nc(cc(c1)N1CCN(CC1)C(=O)C=C)c1noc(n1)[C@@]1(C)CCCc2c1c(C#N)c(N)s2
InChI InChI=1S/C30H37N9O2S/c1-5-25(40)38-12-10-37(11-13-38)20-15-22(33-24(16-20)39-14-9-36(4)18-19(39)2)28-34-29(41-35-28)30(3)8-6-7-23-26(30)21(17-31)27(32)42-23/h5,15-16,19H,1,6-14,18,32H2,2-4H3/t19-,30-/m0/s1
InChI Key CKAMBYUZKWQCKJ-ADSBAMQRSA-N
References
1. Bröker J, Waterson AG, Smethurst C, Kessler D, Böttcher J, Mayer M, Gmaschitz G, Phan J, Little A, Abbott JR et al.. (2022)
Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C Inhibitor.
J Med Chem, 65 (21): 14614-14629. [PMID:36300829]